Form 4 for INMB Inmune Bio, Inc.
Accepted 2024-09-30 00:00:00 ET · period of report 2024-09-30 · accession 0001213900-24-083348 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2024-09-30 | INMB | Moss David J | CFO, 10% | P - Purchase | $5.29 | +10.0K | 1.29M | +0.8% | +$52.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-30 | P | A | 10,000 | $5.29 | 1,285,869 | D | — | — |